Scaling Down for Big Impact: Streamlined High-throughput Recombinant Adeno-associated Virus Production
1Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, Hoffmann-La Roche Ltd, 2Roche Pharma technical development Cell and Gene Therapy, Roche Innovation Center Munich, Roche Diagnostics GmbH, 3Center of Biomedical Education and Research - ZBAF, University of Witten/Herdecke, 4Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, 5Biozentrum, University of Basel
